FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2563625379> ?p ?o ?g. }

• W2563625379 abstract "Previous work (Mol. Pharm. 79: 479-87, 2011) demonstrated that MPO, found in myeloid progenitor cells, oxidized the anticancer agent VP-16 to its phenoxyl radical (VP-O•) and led to enhanced topoisomerase II-mediated strand cleavage through redox cycling resulting in MLL translocations, implicating MPO in VP-16 leukemogenesis. Utilizing shRNA MPO in myeloid leukemia HL60 cells, MPO dependency for VP-16 activity was further established (PAACR 55: 826, 2014). In the present study, we examined the effects of dehydroascorbate (DHA) and trolox on MPO-dependent effects of VP-16, VP-16 catechol (VP-OH) and VP-16 ortho-quinone (VP-oQ, fully oxidized VP-16). In addition, the role of GSH as a mediator of the pro- or anti-oxidant effects of VP-16, its metabolites and several other phenolic agents was evaluated. Using Comet assays, VP-16-induced DNA strand breaks in MPO+ HL60 cells were significantly reduced when cells were pre-incubated with 1 mM DHA; known to act as a reductant of MPO generated VP-O•. In MPO knockdowns, VP-16-induced DNA damage was diminished compared to MPO+ cells. In these MPO knockdowns, DHA did not perturb VP-16-induced DNA damage. Similar results were demonstrated with VP-OH, consistent with MPO-mediated generation of VP-O• and DHA reduction/protection against DNA damage. For VP-oQ, 1,4-benzoquinone, and camptothecin, DNA damage was similar in MPO+ and knockdown cells with no attenuation in the presence of DHA. VP-16 and VP-OH also induced oxidative DNA damage in MPO+ cells which was reduced by DHA. This DNA damage was attenuated in MPO knockdowns with no further effect by DHA. The phenolic vitamin E analog trolox, a known MPO substrate, also reduced oxidative DNA damage induced by VP-16 and VP-OH but not by VP-oQ. Using 3′-(p-hydroxyphenyl) fluorescein (HPF), pro-oxidant activity of VP-16 was demonstrated in MPO+ cells which converted to anti-oxidant effects in MPO knockdowns. Both DHA and trolox protected cells against VP-16-induced pro-oxidant effects in MPO+ cells. When GSH levels were reduced by incubation with buthionine sulfoximine, the pro-oxidant effects of VP-16 in MPO+ cells were eliminated. N-acetyl cysteine (NAC) restored VP-16-induced pro-oxidant activity. In contrast, the pro-oxidant effects of the phenolic agents quercetin and EGCG were found to be independent of MPO and were diminished by addition of NAC. Together, results strongly suggest that MPO-catalyzed oxidation of VP-16 to redox active species leads to enhanced genotoxic events linked to the known leukemogenic action of this anticancer agent. These MPO dependent effects are also dependent on GSH likely through thiyl radical formation and cycling. The protective effects of DHA and trolox further suggest that reduction of MPO-catalyzed VP-16 free radicals may be an effective strategy to prevent drug-induced second malignancies. Support: NIH R01 CA090787. Citation Format: Jason Goodspeed, Soumendra Karmahapatra, Ragu Kanagasabai, Alex Klausing, Jack C. Yalowich. Impact of antioxidants on myeloperoxidase (MPO)-dependent DNA damage and genotoxicity induced by etoposide (VP-16):implications for therapy-induced second malignancies. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 1660. doi:10.1158/1538-7445.AM2015-1660" @default.
• W2563625379 created "2017-01-06" @default.
• W2563625379 creator A5037238715 @default.
• W2563625379 creator A5076989488 @default.
• W2563625379 creator A5077164130 @default.
• W2563625379 creator A5078853335 @default.
• W2563625379 creator A5080340455 @default.
• W2563625379 date "2015-08-01" @default.
• W2563625379 modified "2023-09-27" @default.
• W2563625379 title "Abstract 1660: Impact of antioxidants on myeloperoxidase (MPO)-dependent DNA damage and genotoxicity induced by etoposide (VP-16):implications for therapy-induced second malignancies" @default.
• W2563625379 doi "https://doi.org/10.1158/1538-7445.am2015-1660" @default.
• W2563625379 hasPublicationYear "2015" @default.
• W2563625379 type Work @default.
• W2563625379 sameAs 2563625379 @default.
• W2563625379 citedByCount "0" @default.
• W2563625379 crossrefType "proceedings-article" @default.
• W2563625379 hasAuthorship W2563625379A5037238715 @default.
• W2563625379 hasAuthorship W2563625379A5076989488 @default.
• W2563625379 hasAuthorship W2563625379A5077164130 @default.
• W2563625379 hasAuthorship W2563625379A5078853335 @default.
• W2563625379 hasAuthorship W2563625379A5080340455 @default.
• W2563625379 hasConcept C143425029 @default.
• W2563625379 hasConcept C147897179 @default.
• W2563625379 hasConcept C153911025 @default.
• W2563625379 hasConcept C178790620 @default.
• W2563625379 hasConcept C185592680 @default.
• W2563625379 hasConcept C190283241 @default.
• W2563625379 hasConcept C203014093 @default.
• W2563625379 hasConcept C203565725 @default.
• W2563625379 hasConcept C2776914184 @default.
• W2563625379 hasConcept C2778903051 @default.
• W2563625379 hasConcept C2778959862 @default.
• W2563625379 hasConcept C2779682216 @default.
• W2563625379 hasConcept C2780358455 @default.
• W2563625379 hasConcept C29730261 @default.
• W2563625379 hasConcept C502942594 @default.
• W2563625379 hasConcept C552990157 @default.
• W2563625379 hasConcept C55493867 @default.
• W2563625379 hasConcept C86803240 @default.
• W2563625379 hasConceptScore W2563625379C143425029 @default.
• W2563625379 hasConceptScore W2563625379C147897179 @default.
• W2563625379 hasConceptScore W2563625379C153911025 @default.
• W2563625379 hasConceptScore W2563625379C178790620 @default.
• W2563625379 hasConceptScore W2563625379C185592680 @default.
• W2563625379 hasConceptScore W2563625379C190283241 @default.
• W2563625379 hasConceptScore W2563625379C203014093 @default.
• W2563625379 hasConceptScore W2563625379C203565725 @default.
• W2563625379 hasConceptScore W2563625379C2776914184 @default.
• W2563625379 hasConceptScore W2563625379C2778903051 @default.
• W2563625379 hasConceptScore W2563625379C2778959862 @default.
• W2563625379 hasConceptScore W2563625379C2779682216 @default.
• W2563625379 hasConceptScore W2563625379C2780358455 @default.
• W2563625379 hasConceptScore W2563625379C29730261 @default.
• W2563625379 hasConceptScore W2563625379C502942594 @default.
• W2563625379 hasConceptScore W2563625379C552990157 @default.
• W2563625379 hasConceptScore W2563625379C55493867 @default.
• W2563625379 hasConceptScore W2563625379C86803240 @default.
• W2563625379 hasLocation W25636253791 @default.
• W2563625379 hasOpenAccess W2563625379 @default.
• W2563625379 hasPrimaryLocation W25636253791 @default.
• W2563625379 hasRelatedWork W1782287388 @default.
• W2563625379 hasRelatedWork W1983844345 @default.
• W2563625379 hasRelatedWork W1997286336 @default.
• W2563625379 hasRelatedWork W2018918759 @default.
• W2563625379 hasRelatedWork W2019606944 @default.
• W2563625379 hasRelatedWork W2039382768 @default.
• W2563625379 hasRelatedWork W2041833847 @default.
• W2563625379 hasRelatedWork W2047307745 @default.
• W2563625379 hasRelatedWork W2075375676 @default.
• W2563625379 hasRelatedWork W2085953475 @default.
• W2563625379 hasRelatedWork W2091741205 @default.
• W2563625379 hasRelatedWork W2187835838 @default.
• W2563625379 hasRelatedWork W2343347384 @default.
• W2563625379 hasRelatedWork W2404532127 @default.
• W2563625379 hasRelatedWork W2470337798 @default.
• W2563625379 hasRelatedWork W2530282285 @default.
• W2563625379 hasRelatedWork W2737660756 @default.
• W2563625379 hasRelatedWork W2804255277 @default.
• W2563625379 hasRelatedWork W2974897037 @default.
• W2563625379 hasRelatedWork W3004805041 @default.
• W2563625379 isParatext "false" @default.
• W2563625379 isRetracted "false" @default.
• W2563625379 magId "2563625379" @default.
• W2563625379 workType "article" @default.